Meeting
2022 ASCO Annual Meeting
Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.
Authors
Li yuan Guo
Harbin Medical University Cancer Hospital, Harbin, China
Li yuan Guo , Tiantian Han , Didi Guo , Juan Ma , Yaping Zhao , Fanfeng Bu , Siqi Chen , Wanglong Deng , Ran Ding
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10584)
DOI
10.1200/JCO.2022.40.16_suppl.10584
Abstract #
10584
Poster Bd #
459
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2016 ASCO Annual Meeting
Prospective registry of multiplex testing (PROMPT): A web-based platform to assess cancer risk of genetic variants.
First Author: Michael Francis Walsh
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.
First Author: Alexandra Androsova
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski